Latin America Coronary and Peripheral Stents Market Outlook (2022-2033)

The Latin America coronary and peripheral stents market size is expected to reach US$ 864.5 million by 2033 from US$ 574.8 million in 2024. The market is estimated to record a CAGR of 4.6% from 2025 to 2033.

Executive Summary and Latin America Coronary and Peripheral Stents Market Analysis:

The Latin America coronary and peripheral stents market is developing steadily, driven by rising prevalence of cardiovascular and peripheral vascular diseases across urban and semi-urban populations. Lifestyle changes, increasing rates of obesity, hypertension, and diabetes, as well as growing awareness of minimally invasive treatment options, are expanding demand for interventional procedures. Hospitals in major cities are increasingly adopting coronary stenting as the preferred approach for eligible patients, while peripheral interventions are gradually gaining attention due to complex diabetic and vascular cases. However, market growth is restrained by limited procedural infrastructure in rural regions, uneven access to trained interventional cardiologists, and dependency on imported devices. Price sensitivity within public and private healthcare sectors further influences device adoption. Despite these challenges, gradual improvements in healthcare infrastructure, investment in cath labs, and initiatives to strengthen physician expertise continue to support steady market activity across Latin America.

Latin America Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.  

Latin America Coronary and Peripheral Stents Market Outlook

The Latin America coronary and peripheral stents market is concentrated in major urban hospitals and tertiary-care centers, where coronary stenting dominates procedural volumes. Peripheral stents are increasingly applied in patients with advanced vascular complications, particularly those linked to diabetes and peripheral artery disease. A key driver of the market is growing patient awareness and preference for minimally invasive interventions over surgical alternatives. Physicians in urban hospitals increasingly favor stenting due to shorter recovery times, lower complication rates, and the ability to manage high patient volumes efficiently. Investments in diagnostic angiography, coupled with regional training programs for interventional cardiologists, have improved procedural confidence and expanded access to stent-based therapies. As awareness of cardiovascular risk and early intervention continues to rise, the demand for both coronary and peripheral stents is expected to grow steadily within the region’s more developed healthcare hubs.

Latin America Coronary and Peripheral Stents Market Country Insights

Based on country, the Latin America coronary and peripheral stents market is further segmented into Brazil, Mexico, Argentina, Colombia, Chile, and Peru. Mexico held the largest share in 2024.

Mexico dominates the Latin America coronary and peripheral stents market due to its advanced private healthcare network, high urban procedural volumes, and growing interventional cardiology infrastructure. Major cities host high-capacity tertiary hospitals equipped with modern catheterization laboratories, enabling widespread use of coronary stents. Peripheral stenting is gradually increasing for complex vascular disease management, particularly in diabetic populations. Mexico benefits from a combination of public insurance programs and private hospital coverage, which facilitates access to interventional procedures. Established distributor networks and partnerships with global stent manufacturers ensure timely device availability and technical support. Physician training programs and adoption of standardized treatment protocols further strengthen procedural efficiency and clinical outcomes. Although rural regions face access challenges, Mexico’s scale, infrastructure, and clinical expertise firmly establish it as the leading stents market within Latin America.

Latin America Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

Latin America Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise.

Latin America Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations